title: Push-pull sorbent-based pheresis treatment in an experimental canine endotoxemia model: preliminary report.
abstract: The Biologic-DTPF System (DTPF), an extracorporeal blood treatment device with potential to treat sepsis, was tested in a preliminary study using a canine endotoxemia model. Six dogs were used and they formed four treatment groups, as control group (n=1) and three groups based on the type of sorbent present in the plasma filter (PF) system: sham treatment with no sorbent (n=1), charcoal as sorbent (n=2), and charcoal/silica as sorbent ("silica" group, n=2). Cardiodynamic data were recorded before treatment and every 30 minutes, and blood samples were collected to determine blood chemistry and to detect the levels of endotoxin and selected plasma cytokines: interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor (TNF). The dogs were given Escherichia coli endotoxin (2 mg/kg) as an intravenous drip (extended over a period of 30 minutes). Thirty minutes after the end of infusion all animals except the control were treated with the DTPF system for four hours. To determine the effect of treatment, data collected at one hour from the initiation of treatment until the end of treatment were compared between control and treated dogs. The endotoxin levels in the control dog were higher (P < 0.05) than other groups. The control dog had lower levels of TNF than other groups. The control dog had similar levels of IL-1 (P > 0.05) and higher levels (P < 0.05) at 4 hours into treatment compared to other groups. The control dog had similar levels of IL-6 as other groups (P > 0.05). In the control dog, the mean arterial pressure (MAP) fell and then remained low but stable at 1-4 hours. The charcoal group had lower MAP than the control dog at 1-4 hours (P < 0.05). The silica group had higher MAP levels similar to the control dog. After treatment, the control dog had higher (P < 0.05) values of hematocrit, hemoglobin, calcium, potassium, and albumin compared to the treated groups. As expected for a system removing plasma during sepsis, the DTPF System had some adverse effects on the physiologic status of the dogs, especially when loaded with charcoal sorbent only. The findings of the present study suggest that the filters are capable of eliminating endotoxin and there is some evidence of cytokine removal. Although the charcoal dogs did poorly, addition of silica to the sorbent offset any negative effects. Further work is underway to improve the efficiency of the system, primarily to enhance the capacity of the sorbents for cytokines. A more realistic canine sepsis model with mortality after several days (the Escherichia coli- infected intraperitoneal clot) will also be considered in future studies.
authors.affiliation: Department of Veterinary Clinical Sciences, Purdue University, West Lafayette, IN 47907-1248, USA. peterat@vet.purdue.edu
authors.forename: A T
authors.initials: AT
authors.lastname: Peter
authors.forename: S R
authors.initials: SR
authors.lastname: Ash
authors.forename: J
authors.initials: J
authors.lastname: Steczko
authors.forename: J J
authors.initials: JJ
authors.lastname: Turek
authors.forename: D E
authors.initials: DE
authors.lastname: Blake
authors.forename: D J
authors.initials: DJ
authors.lastname: Carr
authors.forename: W R
authors.initials: WR
authors.lastname: Knab
authors.forename: R H
authors.initials: RH
authors.lastname: Bosley
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000931:Antidotes / Q000627:therapeutic use; D002606:Charcoal; D016207:Cytokines / Q000097:blood; D004195:Disease Models, Animal; D004285:Dogs; D004731:Endotoxins / Q000097:blood; D004867:Equipment Design; D004927:Escherichia coli Infections / Q000401:mortality / Q000628:therapy*; D005260:Female; D006439:Hemodynamics / Q000502:physiology; D008297:Male; D010956:Plasmapheresis / Q000295:instrumentation* / Q000379:methods / Q000401:mortality; D011336:Probability; D012016:Reference Values; D006435:Renal Dialysis / Q000295:instrumentation*; D012772:Shock, Septic / Q000097:blood / Q000401:mortality / Q000628:therapy*; D016060:Sorption Detoxification; D015996:Survival Rate
chemical_list: D000931:Antidotes; D016207:Cytokines; D004731:Endotoxins; D002606:Charcoal